This marks the FIRST antigen rapid test to be approved by Taiwan FDA for the detection of SARS-CoV-2 (COVID-19 virus). Vstrip® will continue to apply for approval from other international regulatory agencies including U.S. FDA (EUA), EU CE certification, and Japan PMDA.
Category Archives: EirGenix
News
- 1
- 2
- Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
- Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy
- Anbogen Secures $12.5 Million USD in Series A Funding, Advancing Precision Oncology Drug Development
- Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
- Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation